Filing Details

Accession Number:
0001127602-15-012337
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-23 17:45:32
Reporting Period:
2015-03-19
Filing Date:
2015-03-23
Accepted Time:
2015-03-23 17:45:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242992 P Timothy Clackson C/O Ariad Pharmaceuticals Inc
26 Landsdowne Street
Cambridge MA 02139
President, R&D, Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-19 10,833 $0.00 439,065 No 4 M Direct
Common Stock Acquisiton 2015-03-19 20,657 $7.56 460,971 No 4 M Direct
Common Stock Disposition 2015-03-19 20,657 $9.00 440,314 No 4 S Direct
Common Stock Disposition 2015-03-20 5,417 $8.84 433,648 No 4 S Direct
Common Stock Acquisiton 2015-03-23 13,333 $0.00 446,981 No 4 M Direct
Common Stock Disposition 2015-03-23 6,667 $8.55 440,314 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2015-03-19 10,833 $0.00 10,833 $0.00
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-03-19 20,657 $0.00 20,657 $7.56
Common Stock Restricted Stock Units Disposition 2015-03-23 13,333 $0.00 13,333 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,833 No 4 M Direct
0 2006-10-04 2015-10-04 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
  2. Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
  3. Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
  4. Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
  5. Shares were acquired upon the exercise of outstanding stock options at $9.00 per share.
  6. Each restricted stock unit represents a right to receive one share of ARIAD common stock.
  7. Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
  8. Restricted Stock Units vest as to 33-1/3% of the award on March 20, 2013, March 20, 2014 and March 20, 2015.